JP2002012513A - Urea-containing whipped cosmetic - Google Patents

Urea-containing whipped cosmetic

Info

Publication number
JP2002012513A
JP2002012513A JP2001089313A JP2001089313A JP2002012513A JP 2002012513 A JP2002012513 A JP 2002012513A JP 2001089313 A JP2001089313 A JP 2001089313A JP 2001089313 A JP2001089313 A JP 2001089313A JP 2002012513 A JP2002012513 A JP 2002012513A
Authority
JP
Japan
Prior art keywords
urea
cosmetic
present
amount
poe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001089313A
Other languages
Japanese (ja)
Inventor
Katsuhiko Yoshida
勝彦 吉田
Daisuke Taguchi
大介 田口
Fumiko Sugano
富美子 菅野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Priority to JP2001089313A priority Critical patent/JP2002012513A/en
Publication of JP2002012513A publication Critical patent/JP2002012513A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain a urea-containing cosmetic excellent in feeling of use and usability. SOLUTION: This urea-containing whipped cosmetic is characterized by filling a cosmetic comprising (A) urea, (B) a urea stabilizer and (C) a surfactant in a non-gas foamer container.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、尿素含有ホイップ
状化粧料に関し、詳しくは、特定の容器に充填され、使
用感及び使用性に優れた尿素含有ホイップ状化粧料に関
する。
The present invention relates to a urea-containing whipped cosmetic, and more particularly, to a urea-containing whipped cosmetic which is filled in a specific container and has excellent feeling and usability.

【0002】[0002]

【従来の技術】NMF(天然保湿因子)の1つとして知
られている尿素は、角質内水分保持作用、創傷治癒作
用、殺菌作用等皮膚に対して優れた作用を有している。
そして尿素を配合した皮膚外用剤が多数開発されてい
る。(特開昭52−105225、特開昭51−484
41、特開平3−291221、特開平4−1129、
特開平6−24954号公報)
2. Description of the Related Art Urea, which is known as one of NMFs (natural moisturizing factors), has excellent effects on the skin, such as water retention in the keratin, wound healing and bactericidal effects.
Many skin external preparations containing urea have been developed. (JP-A-52-105225, JP-A-51-484)
41, JP-A-3-291221, JP-A-4-1129,
JP-A-6-24954)

【0003】しかしこれらの製剤のほとんどは、クリー
ム状、軟膏状、乳液状、ローション状、エアゾール状の
ものである。クリーム状、軟膏状、乳液状の製剤は、塗
布時に配合成分である油性成分由来の油膜感、べたつき
感等の不快感が生じたり、ローション等の製剤と比べ厚
目に塗布されるため、皮膚の上での延展性が十分でない
等の問題があった。一方、ローション状の製剤は、感触
は優れるが、誤飲等の安全性の問題があり、また塗布時
に液の垂れ落ち等が生じ、目的とする部位に均一に塗布
できず、使用性が十分ではなかった。エアゾール状の製
剤についても、感触についてはローション状の製剤と同
様、任意に調整ができ好ましいが、フロン、LPGガス
等の液化ガスを噴射剤として使用するため、引火等の安
全性の問題や、環境問題等から剤型的に好ましくなかっ
た。
However, most of these preparations are in the form of creams, ointments, emulsions, lotions and aerosols. Cream-like, ointment-like and emulsion-like preparations cause discomfort such as oily film feeling and stickiness derived from the oily component which is a compounding component at the time of application, and are applied thicker than preparations such as lotions, so that There is a problem that the extensibility on the surface is not sufficient. On the other hand, lotion-like preparations have a good feel, but have safety problems such as accidental ingestion, and also cause dripping of the liquid at the time of application. Was not. As for the aerosol-based preparation, the feel can be arbitrarily adjusted as in the case of the lotion-based preparation, but it is preferable. It was not preferable in terms of dosage form due to environmental problems and the like.

【0004】[0004]

【発明が解決しようとする課題】したがって、使用感及
び使用性に優れた尿素を含有する化粧料の開発が望まれ
ていた。
Therefore, there has been a demand for the development of a urea-containing cosmetic composition having excellent usability and usability.

【0005】[0005]

【課題を解決するための手段】本発明者等は上記事情に
鑑み、鋭意研究した結果、特定の容器に充填した尿素含
有化粧料が、使用感及び使用性に優れていることを見出
し、本発明を完成したものである。すなわち、本発明
は、(A)尿素、(B)尿素安定剤、及び(C)界面活
性剤を含有する化粧料を、ノンガスフォーマー容器に充
填したことを特徴とする尿素含有ホイップ状化粧料にあ
る。
Means for Solving the Problems In view of the above circumstances, the present inventors have conducted intensive studies and as a result, have found that a urea-containing cosmetic filled in a specific container has excellent feeling and usability. The invention has been completed. That is, the present invention provides a urea-containing whipped cosmetic, characterized in that a cosmetic containing (A) urea, (B) a urea stabilizer, and (C) a surfactant is filled in a non-gas former container. It is in.

【0006】[0006]

【発明の実施の形態】BEST MODE FOR CARRYING OUT THE INVENTION

【0007】以下、本発明の実施の形態を詳述する。Hereinafter, embodiments of the present invention will be described in detail.

【0008】本発明の尿素含有ホイップ状化粧料とは、
(A)尿素、(B)尿素安定剤、及び(C)界面活性剤
を含有する化粧料と空気とが、ノンガスフォーマー容器
によって、混合、噴出されることにより、微細な泡沫状
となったものである。
The urea-containing whipped cosmetic of the present invention is
A cosmetic containing (A) urea, (B) a urea stabilizer, and (C) a surfactant, and air were mixed and ejected by a non-gas former container to form a fine foam. Things.

【0009】本発明に用いられる(A)尿素の配合量
は、化粧料の総量を基準として0.1〜25質量%(以
下、単に%で示す)が好ましく、特に好ましくは1〜2
0%である。配合量が0.1%未満では保湿効果が不十
分の場合があり、25%を超えて配合しても、それに見
合った効果の増大が得られない場合があり、また尿素の
安定性を維持することが困難である。
The amount of the urea (A) used in the present invention is preferably 0.1 to 25% by mass (hereinafter simply referred to as%) based on the total amount of the cosmetic, and particularly preferably 1 to 2%.
0%. If the amount is less than 0.1%, the moisturizing effect may be insufficient, and if it exceeds 25%, the effect may not be increased correspondingly, and the stability of urea is maintained. Is difficult to do.

【0010】本発明に用いられる(B)尿素安定剤は、
通常化粧料において尿素の分解を抑制し、安定化を目的
として配合されるものであれば特に制限されず、例え
ば、乳酸及びその塩類、リン酸及びその塩類、クエン酸
及びその塩類、エデト酸及びその塩類等が挙げられる。
特に、乳酸、乳酸ナトリウムは優れた尿素の安定性を得
ることができ好ましい。
[0010] The (B) urea stabilizer used in the present invention comprises:
It is not particularly limited as long as it is incorporated for the purpose of suppressing the decomposition of urea in normal cosmetics and stabilizing, for example, lactic acid and its salts, phosphoric acid and its salts, citric acid and its salts, edetic acid and And salts thereof.
In particular, lactic acid and sodium lactate are preferable because excellent urea stability can be obtained.

【0011】本発明に用いられる(B)尿素安定剤は、
一種単独又は二種以上を組み合わせて用いることができ
る。その配合量は、化粧料の総量を基準として0.5〜
15%が好ましく、特に好ましくは1〜10%である。
配合量が0.5%未満では尿素の安定性を維持すること
が困難であり、15%を超えて配合した場合、皮膚に一
過性の刺激が生じる場合があり、安全性上好ましくな
い。
The (B) urea stabilizer used in the present invention is:
One type may be used alone, or two or more types may be used in combination. The compounding amount is 0.5 to 0.5% based on the total amount of the cosmetic.
It is preferably 15%, particularly preferably 1 to 10%.
If the amount is less than 0.5%, it is difficult to maintain the stability of urea. If the amount exceeds 15%, transient irritation may occur on the skin, which is not preferable in terms of safety.

【0012】本発明に用いられる(C)界面活性剤は、
通常化粧料に用いられるものであれば特に制限されず、
例えば、ポリオキシエチレンソルビタン脂肪酸エステ
ル、ポリオキシエチレンヒマシ油、硬化ヒマシ油、ポリ
オキシエチレンアルキルエーテル、ポリオキシエチレン
脂肪酸、ポリグリセリン脂肪酸エステル等のノニオン性
界面活性剤、アルキルエーテル硫酸エステル塩、ポリオ
キシエチレンアルキルエーテルリン酸エステル塩、N−
アシルアラニン塩、N−アシルグルタミン酸塩、N−ア
シルアスパラギン酸塩等のアニオン性界面活性剤、ポリ
エーテル変性シリコーン等のシリコーン系界面活性剤等
が挙げられる。特に好ましくは、POE(20)ヤシ油
脂肪酸ソルビタン、POE(20)ラウリン酸ソルビタ
ン、モノオレイン酸POE(20)ソルビタン、POE
(80)硬化ヒマシ油、POEセチルエーテル、モノス
テアリン酸ポリエチレングリコール、モノラウリン酸デ
カグリセリル、POE(3)アルキルエーテル硫酸トリ
エタノールアミン液、ジPOE(10)アルキルエーテ
ルリン酸、N−ヤシ油脂肪酸アシル−DL−アラニント
リエタノールアミン液(30%)、N−ヤシ油脂肪酸ア
シル−L−グルタミン酸トリエタノールアミン液(30
%)、N−アシル−L−アスパラギン酸トリエタノール
アミン液(30%)、POEメチルポリシロキサン共重
合体等であり、前記以外の界面活性剤の場合、尿素の安
定性や、発泡性が十分でない場合がある。
The surfactant (C) used in the present invention comprises:
It is not particularly limited as long as it is usually used for cosmetics,
For example, nonionic surfactants such as polyoxyethylene sorbitan fatty acid ester, polyoxyethylene castor oil, hydrogenated castor oil, polyoxyethylene alkyl ether, polyoxyethylene fatty acid, polyglycerin fatty acid ester, alkyl ether sulfate, polyoxyethylene Ethylene alkyl ether phosphate salt, N-
Examples include anionic surfactants such as acylalanine salt, N-acylglutamate, and N-acylaspartate, and silicone-based surfactants such as polyether-modified silicone. Particularly preferably, POE (20) coconut oil fatty acid sorbitan, POE (20) sorbitan laurate, POE (20) sorbitan monooleate, POE
(80) hydrogenated castor oil, POE cetyl ether, polyethylene glycol monostearate, decaglyceryl monolaurate, POE (3) alkyl ether triethanolamine sulfate solution, diPOE (10) alkyl ether phosphoric acid, N-coconut fatty acid acyl -DL-alanine triethanolamine solution (30%), N-coconut fatty acid acyl-L-glutamate triethanolamine solution (30%)
%), N-acyl-L-aspartic acid triethanolamine solution (30%), POE methylpolysiloxane copolymer and the like. In the case of a surfactant other than the above, the stability of urea and the foaming property are sufficient. May not be.

【0013】本発明に用いられる(C)界面活性剤は、
一種単独又は二種以上を組み合わせて用いることができ
る。その配合量は、化粧料の総量を基準として0.01
〜4%が好ましく、特に好ましくは0.1〜3%であ
る。配合量が0.01%未満では発泡性が不十分な場合
があり、4%を超えて配合した場合、適当な泡の消泡性
が得られにくい。
The surfactant (C) used in the present invention comprises:
One type may be used alone, or two or more types may be used in combination. The compounding amount is 0.01% based on the total amount of the cosmetic.
To 4% is preferable, and particularly preferably 0.1 to 3%. If the amount is less than 0.01%, the foaming properties may be insufficient. If the amount is more than 4%, it is difficult to obtain an appropriate foam defoaming property.

【0014】本発明に用いられる(D)多価アルコール
としては、エチレングリコール、ジエチレングリコー
ル、トリエチレングリコール、ポリエチレングリコー
ル、プロピレングリコール、ジプロピレングリコール、
ポリプロピレングリコール、グリセリン、ジグリセリ
ン、ポリグリセリン、イソプレングリコール、1,3−
ブチレングリコール、POP(9)ジグリセリン、ヘキ
シレングリコール、ソルビトール、マンニトール、マル
チトール、POE(10)メチルグルコシド、POE
(20)メチルグルコシド等が挙げられる。
The polyhydric alcohol (D) used in the present invention includes ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol,
Polypropylene glycol, glycerin, diglycerin, polyglycerin, isoprene glycol, 1,3-
Butylene glycol, POP (9) diglycerin, hexylene glycol, sorbitol, mannitol, maltitol, POE (10) methyl glucoside, POE
(20) Methyl glucoside and the like.

【0015】本発明に用いられる(D)多価アルコール
は、一種単独又は二種以上を組み合わせて用いることが
できる。これらの(D)多価アルコールを適宜配合する
ことにより、尿素含有ホイップ状化粧料の感触、延展性
等を任意に調整することができる。その配合量は、化粧
料の総量を基準として0.1〜20%が好ましく、特に
好ましくは1〜15%である。配合量が0.1%未満で
は肌へのなじみが悪い場合があり、また延展性に欠ける
場合がある。配合量が20%を超える場合、延展性が重
く悪く、乾く際にべたつき感が生じる場合がある。
The polyhydric alcohol (D) used in the present invention can be used alone or in combination of two or more. By appropriately blending these (D) polyhydric alcohols, the feel, spreadability, and the like of the urea-containing whipped cosmetic can be arbitrarily adjusted. The compounding amount is preferably from 0.1 to 20%, particularly preferably from 1 to 15%, based on the total amount of the cosmetic. If the amount is less than 0.1%, the composition may not be well adapted to the skin and may lack spreadability. If the amount is more than 20%, the spreadability is heavy and poor, and a sticky feeling may be caused when drying.

【0016】本発明に用いられるノンガスフォーマー容
器は、容器内の化粧料を空気と混合し、メッシュや多孔
体等の泡生成手段を通過させることにより発泡させ、噴
出するものであり、ポンプフォーマー(大和製罐社製)
等を例示することができる。また、特公昭52−165
67、実公昭60−24426、実開昭62−1034
58、実公昭62−42785、実公昭62−4278
6、実公昭62−42787、実開昭58−17427
2、実開平3−7963、米国特許第4,531,65
9、米国特許第3,709,437号公報、及び特願2
000−349047号の願書に最初に添付された明細
書又は図面等に開示されている様な容器も用いることが
できる。
The non-gas-former container used in the present invention is a container in which the cosmetic in the container is mixed with air, foamed by passing through a foaming means such as a mesh or a porous body, and ejected. Ma (manufactured by Daiwa Seikan)
And the like. In addition, Japanese Patent Publication No. 52-165
67, Shoko 60-24426, Shokai 62-1034
58, Shoko 62-42785, Shoko 62-4278
6, Japanese Utility Model Showa 62-42787, Japanese Utility Model Showa 58-17427
2, Heikai 3-7963, U.S. Pat. No. 4,531,65
9, US Patent No. 3,709,437 and Japanese Patent Application No.
Containers such as those disclosed in the specification or drawings attached to the application No. 000-349047 at the beginning can also be used.

【0017】本発明の尿素含有ホイップ状化粧料には、
上述の必須成分以外に、通常の化粧料、医薬部外品、医
薬品等に用いられる各種任意成分を、本発明の目的を達
成する範囲内で適宜配合することができる。例えば、一
価アルコール、防腐剤、消炎剤、増粘剤、エステル油、
殺菌剤、色素、香料等が挙げられる。
The urea-containing whipped cosmetic of the present invention includes:
In addition to the above-mentioned essential components, various optional components used in ordinary cosmetics, quasi-drugs, pharmaceuticals, and the like can be appropriately compounded within a range that achieves the object of the present invention. For example, monohydric alcohol, preservative, anti-inflammatory, thickener, ester oil,
Fungicides, pigments, fragrances, and the like are included.

【0018】具体的には、一価アルコールとしては、エ
タノール、イソプロパノール、ブタノール、ラウリルア
ルコール、セタノール、ステアリルアルコール、ベヘニ
ルアルコール等が挙げられ、防腐剤としては、メチルパ
ラベン、エチルパラベン、安息香酸ナトリウム、フェノ
キシエタノール等が挙げられ、消炎剤としては、β−グ
リチルレチン酸、グリチルリチン酸ジカリウム、グリチ
ルレチン酸ステアリル、アラントイン等が挙げられ、増
粘剤としては、カルボキシビニルポリマー、カルボキシ
メチルセルロース、ポリビニルアルコール、カラギーナ
ン、ゼラチン等が挙げられ、エステル油としては、高級
アルコールと脂肪酸の合成エステル油等が挙げられる。
Specifically, monohydric alcohols include ethanol, isopropanol, butanol, lauryl alcohol, cetanol, stearyl alcohol, behenyl alcohol and the like. Preservatives include methylparaben, ethylparaben, sodium benzoate, phenoxyethanol and the like. Examples of anti-inflammatory agents include β-glycyrrhetinic acid, dipotassium glycyrrhizinate, stearyl glycyrrhetinate, allantoin, and the like. Examples of ester oils include synthetic ester oils of higher alcohols and fatty acids.

【0019】[0019]

【実施例】以下、実施例により本発明を詳細に説明す
る。
The present invention will be described below in detail with reference to examples.

【0020】実施例1 表1の組成のローションを常法により調製した後、ポン
プフォーマー(大和製罐社製)に充填し、尿素含有ホイ
ップ状化粧料を得た。
Example 1 A lotion having the composition shown in Table 1 was prepared by a conventional method, and then filled into a pump former (manufactured by Daiwa Seikan Co., Ltd.) to obtain a urea-containing whipped cosmetic.

【0021】 (表1) [配合成分] [配合量(%)] ・尿素 10.0 ・乳酸 1.5 ・乳酸ナトリウム 3.5 ・エデト酸二ナトリウム 0.5 ・POE(20)モノラウリン酸ソルビタン 1.0 ・ポリエチレングリコール200 10.0 ・エタノール 20.0 ・純水 残量(Table 1) [Blending components] [Blending amount (%)]-Urea 10.0-Lactic acid 1.5-Sodium lactate 3.5-Disodium edetate 0.5-POE (20) sorbitan monolaurate 1.0 ・ Polyethylene glycol 200 10.0 ・ Ethanol 20.0 ・ Remaining pure water

【0022】比較例1 表1の組成のローションを常法により調製した後、ガラ
ス容器に充填し、尿素含有ローション状化粧料を得た。
Comparative Example 1 A lotion having the composition shown in Table 1 was prepared by a conventional method, and then filled in a glass container to obtain a urea-containing lotion-like cosmetic.

【0023】<使用性・使用感評価試験>パネラー20
名に実施例1及び比較例1の化粧料を1週間連続使用さ
せた後、使い易さ、延展性、さっぱり感(べたつき感の
なさ)の良否を判断してアンケートに答え、その評価を
以下のように判定した。
<Usability / Usability Evaluation Test> Paneler 20
After using the cosmetics of Example 1 and Comparative Example 1 for a week continuously, the quality of ease of use, spreadability, and refreshing feeling (no stickiness) were judged, and the questionnaire was answered. It was determined as follows.

【0024】 評価基準 評価記号 良いと答えた人が18人以上の場合 ◎ 良いと答えた人が14〜17人の場合 ○ 良いと答えた人が8〜13人の場合 △ 良いと答えた人が7人以下の場合 ×Evaluation Criteria Evaluation Symbol 18 or more people answered good ◎ 14-17 people answered good ○ 8-13 people answered good △ Good Is less than 7 ×

【0025】以下、結果を示す。 The results are shown below.

【0026】上記より明らかなように、本発明の尿素含
有ホイップ状化粧料は、使用部位に塗布し易く、延展性
に優れるため、広範囲に均一に塗布することができ、ま
た塗布後にべたつき感がほとんどなく、大変優れた性能
を有していた。一方、ホイップ状でない比較例1の化粧
料は、液の垂れ落ち等のため、使用性に劣り、均一に塗
布することができず、塗布後べたつき感を有していた。
As is evident from the above, the urea-containing whipped cosmetic of the present invention can be easily applied to the site of use and has excellent spreadability, so that it can be applied uniformly over a wide range and has a sticky feeling after application. Very few, very good performance. On the other hand, the cosmetic of Comparative Example 1 which was not whipped was inferior in usability due to dripping of the liquid, could not be uniformly applied, and had a sticky feeling after application.

【0027】実施例2 次の組成のローションを常法により調製した後、ポンプ
フォーマー(大和製罐社製)に充填し、尿素含有ホイッ
プ状化粧料を得た。
Example 2 A lotion having the following composition was prepared by a conventional method, and then filled into a pump former (manufactured by Daiwa Seikan Co., Ltd.) to obtain a urea-containing whipped cosmetic.

【0028】 [配合成分] [配合量(%)] ・尿素 15.0 ・乳酸 5.0 ・乳酸ナトリウム 5.0 ・POE(80)硬化ヒマシ油 0.1 ・グリセリン 1.0 ・エタノール 50.0 ・アロエエキス 残量[Blending components] [Blending amount (%)]-Urea 15.0-Lactic acid 5.0-Sodium lactate 5.0-POE (80) hydrogenated castor oil 0.1-Glycerin 1.0-Ethanol 50. 0 ・ Aloe extract remaining

【0029】実施例3 次の組成のローションを常法により調製した後、ポンプ
フォーマー(大和製罐社製)に充填し、尿素含有ホイッ
プ状化粧料を得た。
Example 3 A lotion having the following composition was prepared by a conventional method, and then charged into a pump former (manufactured by Daiwa Seikan Co., Ltd.) to obtain a urea-containing whipped cosmetic.

【0030】 [配合成分] [配合量(%)] ・尿素 5.0 ・乳酸 0.3 ・乳酸ナトリウム 1.2 ・モノラウリン酸デカグリセリル 3.0 ・1,3−ブチレングリコール 15.0 ・エタノール 5.0 ・グリチルリチン酸ジカリウム 0.1 ・メチルパラベン 0.1 ・純水 残量[Blending components] [Blending amount (%)] ・ Urea 5.0 ・ Lactic acid 0.3 ・ Sodium lactate 1.2 ・ Decaglyceryl monolaurate 3.0 ・ 1,3-butylene glycol 15.0 ・ Ethanol 5.0 ・ Dipotassium glycyrrhizinate 0.1 ・ Methylparaben 0.1 ・ Remaining pure water

【0031】実施例2〜3の尿素含有ホイップ状化粧料
はいずれも優れた使用感及び使用性を有していた。
Each of the urea-containing whipped cosmetics of Examples 2 and 3 had excellent feeling and usability.

【0032】[0032]

【発明の効果】以上記載のごとく、本発明の尿素含有ホ
イップ状化粧料は、使用感及び使用性に優れていること
は明らかである。
As described above, it is clear that the urea-containing whipped cosmetic of the present invention is excellent in use feeling and usability.

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C083 AA112 AC102 AC111 AC122 AC302 AC422 AC432 AC442 AC532 AC681 AC682 AD042 AD532 BB01 CC02 DD08 EE06 EE12  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C083 AA112 AC102 AC111 AC122 AC302 AC422 AC432 AC442 AC532 AC681 AC682 AD042 AD532 BB01 CC02 DD08 EE06 EE12

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 (A)尿素、(B)尿素安定剤、及び
(C)界面活性剤を含有する化粧料を、ノンガスフォー
マー容器に充填したことを特徴とする尿素含有ホイップ
状化粧料。
1. A urea-containing whipped cosmetic, characterized in that a cosmetic containing (A) urea, (B) a urea stabilizer, and (C) a surfactant is filled in a non-gas former container.
【請求項2】 更に、(D)多価アルコールを含有する
ことを特徴とする請求項1記載の尿素含有ホイップ状化
粧料。
2. The urea-containing whipped cosmetic according to claim 1, further comprising (D) a polyhydric alcohol.
JP2001089313A 2000-04-24 2001-03-27 Urea-containing whipped cosmetic Pending JP2002012513A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2001089313A JP2002012513A (en) 2000-04-24 2001-03-27 Urea-containing whipped cosmetic

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000-122110 2000-04-24
JP2000122110 2000-04-24
JP2001089313A JP2002012513A (en) 2000-04-24 2001-03-27 Urea-containing whipped cosmetic

Publications (1)

Publication Number Publication Date
JP2002012513A true JP2002012513A (en) 2002-01-15

Family

ID=26590628

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001089313A Pending JP2002012513A (en) 2000-04-24 2001-03-27 Urea-containing whipped cosmetic

Country Status (1)

Country Link
JP (1) JP2002012513A (en)

Cited By (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018530A2 (en) 2003-08-25 2005-03-03 Foamix Ltd. Penetrating pharmaceutical foam
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US8119106B2 (en) 2003-04-28 2012-02-21 Foamix Ltd Foamable iodine compositions
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
JP2017214407A (en) * 2014-12-24 2017-12-07 株式会社ポーラファルマ External composition for screen foamer
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne

Cited By (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
AU2004266502B2 (en) * 2002-10-25 2010-09-23 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119106B2 (en) 2003-04-28 2012-02-21 Foamix Ltd Foamable iodine compositions
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US8114385B2 (en) 2003-08-04 2012-02-14 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
WO2005018530A2 (en) 2003-08-25 2005-03-03 Foamix Ltd. Penetrating pharmaceutical foam
WO2005018530A3 (en) * 2003-08-25 2005-10-20 Foamix Ltd Penetrating pharmaceutical foam
US7645803B2 (en) 2005-05-09 2010-01-12 Foamix Ltd. Saccharide foamable compositions
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
JP2017214407A (en) * 2014-12-24 2017-12-07 株式会社ポーラファルマ External composition for screen foamer
US10265268B2 (en) 2014-12-24 2019-04-23 Pola Pharma Inc. External composition for screen foamers
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne

Similar Documents

Publication Publication Date Title
JP2002012513A (en) Urea-containing whipped cosmetic
TW510801B (en) Skin toning formulation
US20090005449A1 (en) Structured compositions comprising betaine
US20120164357A1 (en) External Preparation
EP2074984A1 (en) Methods of making and using structured compositions comprising betaine
EP1704897B1 (en) Foamable cosmetic compositions
JP4123028B2 (en) Skin cosmetics
JP5189836B2 (en) Oil-containing cosmetic composition
JP2004035458A (en) Transparent liquid cosmetic
JP3649619B2 (en) Composition for external use
JP2001316233A (en) Composition for shaving
KR101904708B1 (en) Sparkling cosmetic composition for cleansing
JP5777859B2 (en) Emulsified composition
JP3675637B2 (en) Composition for external use
TWI714554B (en) Aerosol composition for capturing carbon dioxide, method of preparing the same, and cosmetics including the same
GB2315771A (en) Non-foamable gel shaving composition
JP2021054721A (en) Method for improving stickiness of adenosine-phosphate-containing composition
JPH1087454A (en) Unfoamable gel-like shaving agent composition
JP3765465B2 (en) Oil-in-water emulsion composition
JP3649620B2 (en) Composition for external use
US20040067211A1 (en) Emulsion composition
JP2681665B2 (en) Cosmetics
KR100777625B1 (en) Emulsion composition
JP4529402B2 (en) Skin cosmetics
WO2022137030A1 (en) Compositions comprising cocamidopropyl betaine and at least one fatty acid

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20040805

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20040806

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20060328

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060921

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20080218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080226

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080417

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080513